Koyfin Home > Directory > Health Care > Acorda Therapeutics > Altman Z-score

Acorda Therapeutics Altman Z-score Chart (ACOR)

Acorda Therapeutics annual/quarterly Altman Z-score from 2010 to 2020.
  • Acorda Therapeutics Altman Z-score for the quarter ending June 06, 2020 was -1.50 a 38.70% decrease of -0.58 year over year
  • Acorda Therapeutics Altman Z-score for the last 12 months ending June 06, 2020 was -1.38 a 63.63% decrease of -0.88 year over year
  • Acorda Therapeutics Annual Altman Z-score for 2019 was -0.77 a 294.31% decrease of -2.28 from 2018
  • Acorda Therapeutics Annual Altman Z-score for 2018 was 1.51 a 3.45% increase of 0.05 from 2017
  • Acorda Therapeutics Annual Altman Z-score for 2017 was 1.45 a 11.67% increase of 0.17 from 2016
Other Balance Sheet Metrics:
  • Acorda Therapeutics Total Assets for the quarter ending December 12, 2018 was $1,300m a 8.66% increase of 113m year over year
  • Acorda Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $204m a 10.59% increase of 22m year over year
  • Acorda Therapeutics Total Equity for the quarter ending December 12, 2018 was $612m a 10.14% increase of 62m year over year
View Chart On Koyfin

Quarterly ACOR Altman Z-score Data

06/2020-1.50
03/2020-1.40
12/2019-0.81
09/2019-0.92
06/2019-0.06
03/20190.21
12/20180.74
09/20181.92
06/20182.08
03/20181.33

Annual ACOR Altman Z-score Data

2019-0.77
20181.51
20171.45
20161.28
20152.44
20142.13
20135.52
20123.86
20113.96
20103.28